ELV · 10-Q · 2026Q2 · Full report

Liquidity Outlook and Funding Sources

Elevance Health, Inc. · 2026-07-15 · Importance 43 · Surprise 6 · Matches filing data

Management believes cash on hand, future operating cash receipts, investments and funds available under the commercial paper program, the $5,000 million 5-Year Facility and FHLB borrowings will be adequate to fund expected cash disbursements over the next twelve months.,The company had $0 outstanding commercial paper and $0 short-term FHLB borrowings at June 30, 2026, providing immediate liquidity capacity if market issuance is required.,Elevance states it expects funds from future operating cash flows, cash and investments and its 5-Year Facility or other financing sources to be sufficient for future operations, commitments and capital acquisitions.

Key facts

• The 5-Year Facility provides credit of up to $5,000 and matures in September 2030, and its covenants include a defined debt-to-capital ratio of not more than 60%. source
• We have an authorized commercial paper program of up to $5,000. source
• As of June 30, 2026, our debt-to-capital ratio, as defined and calculated under the 5-Year Facility, was 40.8% and we were in compliance with all of our debt covenants under the 5-Year Facility. source
• We are a member of four Federal Home Loan Banks and had $0 of outstanding short-term borrowings from the FHLBs as of June 30, 2026 and $150 as of December 31, 2025. source
• We believe that cash on hand, future operating cash receipts, investments and funds available under our commercial paper program, our 5-Year Facility and borrowings available from the FHLBs will be adequate to fund our expected cash disbursements over the next twelve months. source
• There have been no material changes to our long-term liquidity requirements as disclosed in Part II, Item 7 of our 2025 Annual Report on Form 10-K. source
• We had $0 of outstanding commercial paper at June 30, 2026 and $0 at December 31, 2025. source

Impact estimates